Markets
US-ENTERTAINMENT-PRIZE-BREAKTHROUGH
Serial SPAC sponsor Chamath Palihapitiya (Etienne Laurent / Getty Images)

Return of the SPAC

Oh my god.

It looks like one of my favorite feats of financial engineering might be mounting a comeback. From The Financial Times:

New fundraising [for SPACs] has been improving slowly this year, rising about 20 per cent over the same period of 2023 to $3.1bn, according to Dealogic, and advisers are expecting activity to pick up pace. More than 20 Spacs have filed IPO documents since the start of June, targeting a combined $4.3bn in fundraising. That compares with just $1.8bn raised in the entire second half of 2023.

“There are over 1,300 unicorns out there, and the exit route on both the IPO side and the strategic M&A side has been closed,” said Jimmy Fang, chief operating officer at Spac sponsor Explorer Acquisitions. “Even in the hottest tech IPO market ever, you’re unlikely to get more than 150 IPOs in one year. What happens to the remaining companies? . . . I’m not saying SPACs will fill the entire void there, but I certainly believe they can fill a sizable amount.”

SPACs, obviously, got overhyped in 2020 and 2021, considering that everyone from NBA champion Shaquille O’Neal to former Speaker of the House Paul Ryan launched a SPAC, and as the market grew frothier, the quality of “businesses” going public in SPAC deals deteriorated.

Electric vehicle startups with no revenue, electric scooter startups with broken business models,  marijuana seller review platforms, and rare earth metal-based battery producers not expected to be cash flow-positive for six years all went public through SPACs, and, as you could guess, most didn’t perform too well in the public markets.

However, not every company that went public through a SPAC was a bad company. School bus manufacturer Blue Bird, IT infrastructure provider Vertiv, sports betting platform DraftKings, and potato chip maker Utz all went public through reverse mergers with SPACs, and they’ve fared quite well in public markets. The issue is less “SPACs” and more the quality of a company that looked to go public through a reverse merger with a SPAC.

SPACs provide an expedited IPO process with less regulatory hurdles than traditional IPOs. In 2021, the public market appetite for new listings was massive, so “good” companies had no trouble going public through an IPO, and the only companies willing to do a SPAC deal would have been those that couldn’t attract the investor interest needed to support a traditional IPO (for context, Blue Bird, DraftKings, and Vertiv all announced their deals well before the pandemic, and Utz announced its deal in June 2020, before valuations got crazy). Naturally, many of these companies had no business being public.

However, IPO markets are now frozen, many venture and private equity investors need exits to return capital to their investors, and many of their portfolio companies are either 1) worth more than $1 billion, 2) profitable, or 3) both. If the IPO market remains cold, SPACs could become an attractive alternative to get portfolio companies to the public markets.

More Markets

See all Markets
markets

Health insurance stocks lose steam as Trump says he’ll lobby insurers for lower prices

Shares of health insurance companies dropped Friday afternoon, as President Trump said he would ask insurers to meet with him in the coming weeks to seek lower prices.

Stocks including Humana, UnitedHealthcare, Cigna, CVS Health, and Elevance Health all either pared gains or went further into the red after Trump’s remarks, which came at the end of a press event to announce pricing deals with nine drugmakers.

“I’m going to call a meeting of the big insurance companies that have gotten so rich,” Trump said, noting that he would lobby them for lower prices.

“I would say that maybe with one talk, they would be willing to cut their prices by 50, 60, or 70%. They’ve made a fortune.”

markets

Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades

Shares of EV maker Rivian are on pace to close up double digits for the second day in a row on Friday as bullish investors pour into the stock following analyst upgrades.

Rivian shares were up more than 10% on Friday afternoon, with the stock climbing to its highest level since December 2023.

Webush’s Dan Ives boosted his Rivian price target by 56% to $25 in a note on Friday morning. The analyst wrote that 2026 is a “prove-me” year for the automaker, with its lower-cost R2 model set to launch in the first half.

Ives’s note follows a separate optimistic bit of analysis from Baird, which also boosted its Rivian price target to $25 in a note on Thursday.

If today's gains hold, Friday will mark the third day of double-digit gains for Rivian in the past six trading days. An “AI Day” event that saw the automaker detail autonomous updates and tease a robotaxi plan started the recent run.

markets
Luke Kawa

The neoclouds are shooting back up into the stratosphere

Investors’ faith in tech CEOs’ pursuit of digital God has seemingly been restored for now, sparking an intense rally in the speculative AI players that had been in full-on meltdown mode over concerns that the boom had passed its best-before date.

The data center companies colloquially known as the “neoclouds” — CoreWeave, Nebius, IREN, and Cipher Mining — are up more than double digits over the past two sessions, as of 10:40 a.m. ET.

The past 48 hours have brought a steady drumbeat of positive news for the AI theme.

CoreWeave received a vote of confidence from Wall Street as Citi resumed coverage with a buy rating and price target of $135. Oracle, the epicenter of AI credit concerns, has seen a reversal in its fortunes as it nears an acquisition of TikTok’s US operations. And OpenAI’s fundraising efforts appear be going so well that its reported valuation has gone up in back-to-back days.

Before that, Micron’s earnings reaffirmed the intense demand for AI compute, which continues to outstrip supply — a positive sign for the neoclouds. The macro backdrop is also turning perhaps a bit more in favor of lower interest rates, as CPI inflation came in well below expectations.

Snoop Dogg Performs At OVO Hydro Glasgow

Marijuana rescheduling could mean more investment in US weed stocks. There aren’t many ways in.

“Yes, institutional capital will go into the underlying names. The question is: How fast?" one weed company chairman said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.